Opdivo (Nivolumab) for the Treatment of Unresectable or Metastatic Melanoma
Opdivo (nivolumab) is indicated for the treatment of unresectable or metastatic melanoma in...
Trending menu:
-
![]()
Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes
-
![]()
Nerlynx (neratinib) for the Treatment of Breast Cancer
-
![]()
Olumiant (baricitinib) for the Treatment of Moderate-to-Severe Rheumatoid Arthritis
-
![]()
Cabometyx (cabozantinib) for Treatment of Patients with Advanced Renal Cell Carcinoma
-
![]()
Keytruda (pembrolizumab) for the Treatment of Metastatic Melanoma
-
![]()
Tremfya (guselkumab) for the Treatment of Plaque Psoriasis
Most Read
- FDA accelerated review denial is a blow to Spectrum’s poziotinib
- New drugs and therapeutic options help the immune system fight cancer
- Roche’s Tecentriq threatens BMS’ Opdivo in small cell lung cancer market
- The challenges of using stem cells in neurology
- Another BACE inhibitor fails in phase III trials
Company A-Z
Latest Content
Evolution Research and Invicro to offer clinical research services
Evolution Research Group (ERG) and Konica Minolta’s Invicro have collaborated to provide early-to-late-phase clinical research services for biotech and pharma sponsors.
3DforScience Will Attend Medica Trade Fair
Once again, 3DforScience will be attending MEDICA 2019 in Germany at Dusseldorf. This annual meeting persists to be the world’s largest medical technology tradeshow. With more than 130,000 attendees from nearly 70 countries.
Janssen reimagines digital clinical trial design with CHIEF-HF
The Janssen Pharmaceutical Companies of Johnson & Johnson is reimagining digital clinical trial design with the launch of a new study.
Javara to offer clinical trials within Privia Health’s care centres
Integrated research organisation (IRO) Javara and medical group Privia Health are partnering to provide clinical trials to Privia Medical Group’s Gulf Coast and Georgia region’s patients.
Tmunity enters strategic collaboration with Oncora Medical
Clinical-stage biotherapeutics company Tmunity Therapeutics will be granted access to Oncora Medical's proprietary real-world data platform after the companies formed a strategic collaboration.
Parexel and SCRS collaborate to boost trial diversity and engagement
Biopharmaceutical services provider Parexel has formed a strategic collaboration with the Society for Clinical Research Sites (SCRS), an organisation focused on representing clinical research site interests.
Gilead and Glympse partner on biomarker technology use
US antiviral drugmaker Gilead Sciences has formed a strategic collaboration with Glympse Bio to explore the use of biomarker technology in nonalcoholic steatohepatitis (NASH) clinical development.
Oracle and Phlexglobal partner on clinical research
Oracle Health Sciences and Trial Master File (TMF) technology provider Phlexglobal have collaborated to accelerate the speed and accuracy of regulatory compliance, as well as inspection readiness in clinical trials.
Trial to test insomnia drug for alcohol use disorder
Researchers at The Florey Institute of Neuroscience and Mental Health and St Vincent’s Hospital in Australia have commenced a clinical trial of Belsomra (suvorexant) for the prevention of alcohol intake and alcohol use disorder relapse.
Manufacturers Choose the Mastersizer 3000 for Accuracy and Efficiency
In 2016, Metals and Additives LLC, a leading manufacturer and supplier of powder additives for the battery and plastics industries, purchased the Mastersizer 3000 from Malvern Panalytical.
Latest News
Close
Close
Close
Go Top
